Blueprint Medicines Corpo...
104.97
2.41 (2.35%)
At close: Jan 15, 2025, 9:44 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Revenue 249.38M 204.04M 180.08M 793.74M 66.51M 44.52M 21.43M 27.77M 11.40M n/a n/a
Cost of Revenue 12.80M 17.81M 17.93M 425.00K n/a 243.62M 144.69M 81.13M 48.59M 31.84M 15.93M
Gross Profit 236.58M 186.22M 162.15M 793.31M 66.51M -199.10M -123.26M -53.36M -37.19M -31.84M -15.93M
Operating Income -486.28M -549.25M -648.46M 302.15M -366.58M -247.03M -149.48M -73.61M -53.02M -39.83M -20.77M
Interest Income n/a 17.75M 2.39M 6.60M 13.73M 10.64M 3.42M n/a n/a n/a n/a
Pretax Income -506.02M -552.28M -641.08M 314.94M -347.69M -236.64M -148.12M -72.50M -52.77M -40.28M -20.91M
Net Income -506.98M -557.52M -644.09M 313.88M -328.70M -236.64M -148.12M -72.50M -52.77M -40.28M -20.91M
Selling & General & Admin 295.14M 237.37M 195.29M 157.74M 96.39M 47.93M 27.99M 19.22M 14.46M 7.89M 5.07M
Research & Development 427.72M 477.42M 601.03M 326.86M 331.45M 243.62M 144.69M 81.13M 48.59M 31.84M 15.93M
Other Expenses n/a 8.95M 7.80M -366.00K -100.00K 10.46M 3.35M 551.00K -429.00K -98.00K 226.00K
Operating Expenses 722.86M 723.74M 804.13M 484.60M 427.84M 291.55M 172.67M 100.35M 63.04M 39.73M 21.00M
Interest Expense n/a 16.77M n/a n/a 13.73M 73.00K 221.00K 469.00K 696.00K 453.00K 138.00K
Selling & Marketing Expenses 16.90M 18.10M 13.50M 9.40M 3.30M n/a n/a n/a n/a n/a n/a
Cost & Expenses 735.66M 741.55M 822.06M 485.03M 427.84M 291.55M 172.67M 100.35M 63.04M 39.73M 21.00M
Income Tax 968.00K 5.24M 3.00M 1.06M -18.99M 10.46M 1.99M -562.00K -681.00K 355.00K 364.00K
Shares Outstanding (Basic) 60.56M 59.64M 58.52M 54.53M 47.83M 43.87M 37.79M 27.49M 18.24M 13.08M 13.08M
Shares Outstanding (Diluted) 60.56M 59.64M 58.52M 56.17M 47.83M 43.87M 37.79M 27.49M 18.24M 13.08M 13.08M
EPS (Basic) -8.37 -9.35 -11.01 5.76 -6.87 -5.39 -3.92 -2.64 -2.89 -3.08 -1.6
EPS (Diluted) -8.37 -9.35 -11.01 5.59 -6.87 -5.39 -3.92 -2.64 -2.89 -3.08 -1.6
EBITDA -470.36M -515.41M -628.30M 308.71M -356.07M -242.78M -149.67M -70.44M -51.13M -39.11M -20.50M
Depreciation & Amortization 11.66M 20.10M 12.79M 12.35M 10.25M 4.25M 1.58M 1.58M 948.00K 622.00K 501.00K